Form 4: Concentrix Director Dennis Polk Awarded 7,701 RSUs
Insider Transaction Report
Concentrix Corp Director Dennis Polk received an award of 7,701 restricted stock units, aligning his interests with shareholders.
Summary
- Dennis Polk, a Director of Concentrix Corp (CNXC), was awarded 7,701 shares of common stock.
- The transaction occurred on March 25, 2026, and represents restricted stock units (RSUs) granted under the 2020 Stock Incentive Plan.
- These RSUs vest in full on the earlier of the one-year anniversary of the grant date or the date of the Issuer's 2027 Annual Meeting of Stockholders.
- Following this acquisition, Dennis Polk beneficially owns a total of 28,924 shares of Concentrix Corp common stock.
- The acquisition price for these RSUs was $0, which is typical for equity grants.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, as it represents a standard practice of aligning director incentives with shareholder interests through equity compensation, without indicating any negative operational or financial news.
Positives
- The award of restricted stock units to Director Dennis Polk aligns his financial interests with those of the company's shareholders, incentivizing long-term performance.
- Equity compensation is a standard practice for retaining and motivating key directors and executives.
Future Outlook
The restricted stock units granted to Director Dennis Polk are scheduled to vest in full on the earlier of March 25, 2027 (one-year anniversary of the grant date) or the date of Concentrix Corp's 2027 Annual Meeting of Stockholders.
Industry Context
StockSavvy.ai notes that the grant of restricted stock units to a director is a common form of executive and director compensation across various industries. This practice is designed to align the interests of company leadership with long-term shareholder value creation, a prevalent trend in corporate governance.
Comparison to Industry Standards
- Equity-based compensation, such as restricted stock units, is a widely adopted practice for non-employee directors in publicly traded companies, consistent with global benchmarks for corporate governance and incentive alignment.
- The vesting schedule, tied to either a one-year anniversary or the next annual meeting, is a typical structure for director equity awards, similar to practices observed at peer companies in the business services and technology sectors.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Dennis Polk | NA | NA |
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's long-term interests with shareholder value creation, potentially leading to more focused decision-making for company growth.
Next Steps
- The restricted stock units will vest in full on the earlier of March 25, 2027, or the date of Concentrix Corp's 2027 Annual Meeting of Stockholders.
Key Dates
| Date | Description |
|---|---|
| 03/25/2026 | Transaction Date: Acquisition of 7,701 restricted stock units by Dennis Polk. |
| 03/27/2026 | Signature Date of the Form 4 filing by Andrew A. Farwig, Attorney-in-Fact. |
| 03/25/2027 | Earliest potential vesting date (one-year anniversary of grant date) for the restricted stock units. |
| 2027 | Potential vesting date (date of the Issuer's 2027 Annual Meeting of Stockholders) for the restricted stock units. |
Keywords
Concentrix Corp, CNXC, Dennis Polk, Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Award, Stock Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.